This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The General Hospital Corporation, Massachusetts Eye and Ear Infirmary, University of Massachusetts. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,076 
2 out of 276 
1 out of 1,630 
Years Active: 2019-2025
Title: Innovations of Mien Van Hoang
Introduction
Mien Van Hoang is an accomplished inventor based in Braintree, MA, known for his significant contributions to the field of biotechnology. He holds two patents that focus on modified Mullerian inhibiting substance (MIS) proteins and their applications in treating various diseases. His work has the potential to impact cancer treatment and neurodegenerative disorders.
Latest Patents
Mien Van Hoang's latest patents include innovative methods and compositions involving modified recombinant human MIS proteins. The first patent describes a modified MIS protein that exhibits improved cleavage, increased bioactivity, and enhanced potency compared to the wild-type human MIS protein. This invention outlines methods for preventing and treating cancers that express the MIS receptor type II (MISRII) by administering a composition containing the recombinant human MIS protein. Additionally, it discusses methods to lower plasma androgen levels and reduce the required dosage of chemotherapeutic agents when used in conjunction with the recombinant MIS protein. The second patent focuses on using viral vectors to express a modified MIS protein for treating neurodegenerative diseases, particularly motor neuron diseases. This approach involves administering a recombinant human MIS protein with a modified Kex cleavage site for increased efficacy.
Career Highlights
Throughout his career, Mien Van Hoang has worked with notable institutions, including The General Hospital Corporation and Massachusetts Eye and Ear Infirmary. His experience in these organizations has contributed to his expertise in the development of innovative biotechnological solutions.
Collaborations
Mien Van Hoang has collaborated with esteemed colleagues such as Patricia K. Donahoe and Demetrios Vavvas, further enhancing the impact of his research and inventions.
Conclusion
Mien Van Hoang's work in developing modified MIS proteins showcases his dedication to advancing medical science and improving treatment options for various diseases. His innovative patents reflect a commitment to addressing critical health challenges through biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile